Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. User Boards ›
  4. NASDAQ OMX GlobeNewswire Message Board

Beyond Celiac Announces Innovative Collaborative R

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 301275
(Total Views: 256)
Posted On: 09/06/2017 1:00:23 PM
Avatar
Posted By: News Desk 2018
Beyond Celiac Announces Innovative Collaborative Research Effort: Go Beyond Celiac digital community

Philadelphia, PA, Sept. 06, 2017 (GLOBE NEWSWIRE) -- Beyond Celiac has announced the launch of Go Beyond Celiac ™ , a digital community that will enable Beyond Celiac to accelerate treatment options by engaging people with celiac disease, creating an online portal to amass critical data that are not uniformly collected and curated today, including qualitative data about the experience of living with celiac disease, the path to diagnosis and disease management. Go Beyond Celiac is designed to make it easier for people with celiac disease to share their stories at a population level with researchers and participate in research, including clinical trials.

"Each person's experience of celiac disease is unique, from the symptoms a person has before diagnosis to how the disease responds to the gluten-free diet. A rich dataset of patients' journeys would help researchers focus on the important questions whose answers could ultimately improve the lives of those with the disease," notes Jake Hughey, PhD, a researcher at Vanderbilt University Medical Center who has celiac disease himself.

When diagnosed with celiac disease, a patient is typically told the gluten-free diet is a cure for the autoimmune disease. However, that’s far from the truth. In fact, the gluten-free diet is an unreliable and incomplete treatment. In a recent Beyond Celiac survey, 20% of survey respondents said they have symptoms of gluten exposure at least once a month. Ciaran P. Kelly, MD, Beyond Celiac Board Member and the Director of the Celiac Center at Beth Israel Deaconess Medical Center/Professor of Medicine at Harvard Medical School notes, “At least 10 percent of those with celiac disease who follow a gluten-free diet have ongoing or recurrent celiac disease-related symptoms or signs and physicians are not sure why that is whether it is continued exposure or other causes.” Further, people with celiac disease report a very high burden of disease , comparable to end stage renal disease. In one study , 25% of patients stated that the diet is so burdensome they regretted being diagnosed and would rather have continued having symptoms.

Go Beyond Celiac will capture patient data, including:

  • Experiences before, during and after diagnosis
  • Past and current symptoms
  • Psychosocial and economic impacts of living with celiac disease

  Go Beyond Celiac also provides personalized interaction between community members and creates opportunities for dialog to identify unmet needs and opportunities for improved diagnoses, treatments, and to help our community live life to the fullest.

“My son Mitchell was diagnosed with celiac disease after four years of being told that he had a very rare condition called Periodic Fever Syndrome.  He suffered needlessly from the ages of 10-15 and missed out on so much. We had been all over the country searching for answers for him, even after doctors gave up and labeled him a psych case because they couldn't figure it out.  Finally getting a definitive celiac disease diagnosis was such a relief.  Your organization was one of the first we turned to for information. Support for research that will be accelerated through Go Beyond Celiac will spare other families from many hours and much heart ache.”

Go Beyond Celiac will also include a secure, one-of-a-kind celiac disease registry that will keep the community up to date on the latest in medical research and available clinical trials for which they qualify and in which they may wish to participate. In addition, the Go Beyond Celiac registry will be used to assist researchers in pre-screening and recruiting potential participants, reducing a barrier to successful research, accelerating opportunities to improve diagnosis rates, and helping people with celiac disease cope with this serious genetic autoimmune disorder.

In addition, Beyond Celiac also announced that on November 9 th , the organization will host the first ever Bold Beyond Research Symposium , bringing together noted researchers, clinicians and community members to explore the current state and future directions of celiac disease research. The Symposium, which will be held on the Drexel University campus and also webcast to a live audience worldwide, is planned to spur dialogue about research-community partnerships and drive celiac disease community involvement through Go Beyond Celiac.

The Bold Beyond Research Symposium, moderated by Alice Bast, Beyond Celiac CEO, will consist of a live panel presentation and discussion, featuring:

  • Ciaran P. Kelly, MD, Director, Celiac Center and Director, Gastroenterology Fellowship Training, Beth Israel Deaconess Medical Center; Professor of Medicine, Harvard Medical School
  • Anthony J. DiMarino, Jr., MD,  Chief, Division of Gastroenterology & Hepatology, Thomas Jefferson University Hospital
  • Ritu Verma, MD , Section Chief, Gastroenterology, The Children's Hospital of Philadelphia; Associate Professor of Clinical Pediatrics, Perelman School of Medicine at the University of Pennsylvania

“The gluten-free diet is an incomplete and unreliable treatment, and yet it’s all we’ve got,” says Alice Bast, CEO of Beyond Celiac. “No other options have been developed since gluten was identified as the culprit in celiac disease some 70 years ago. We deserve better. We need a 21 st century research agenda and Go Beyond Celiac and the Research Symposium are designed to speed our community’s progress.” People with celiac disease are invited to join Go.BeyondCeliac.org to participate in advancing research in the field. For more information about attending the Bold Beyond Research Symposium either in the live audience or via webcast, visit www.BeyondCeliac.org/BoldBeyondSymposium.

About Beyond Celiac Beyond Celiac, a 501 (c)(3) non-profit organization formerly known as the National Foundation for Celiac Awareness, unites with patients and partners to drive diagnosis, advance research and accelerate the discovery of new treatments and a cure. For more information, please visit www.beyondceliac.org.

Attachments:

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/Attachm...e7d6846f11

Attachments:

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/Attachm...e8c0196e08

Attachments:

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/Attachm...599435763d

Claire Baker Beyond Celiac` 215-325-1306 ext. 111 cbaker@beyondceliac.org



(0)
(0)








Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us